A Genentech-partnered Vijay Pande favorite nabs $52M to advance an AI pipeline
Evan Feinberg could have picked a better time to launch his AI biotech, Genesis. He announced a $4.1 million round last November; by March, South San Francisco, California was under lockdown.
Still, a year later, he can look back at his early tenure with a certain degree of satisfaction.
“To see the things we’ve accomplished, all from my couch?” Feinberg told Endpoints News. “It’s really bizarre.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.